Yong Wu

3.3k total citations
111 papers, 2.4k citations indexed

About

Yong Wu is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Yong Wu has authored 111 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 33 papers in Cancer Research and 21 papers in Surgery. Recurrent topics in Yong Wu's work include Cancer-related molecular mechanisms research (26 papers), Circular RNAs in diseases (17 papers) and RNA modifications and cancer (14 papers). Yong Wu is often cited by papers focused on Cancer-related molecular mechanisms research (26 papers), Circular RNAs in diseases (17 papers) and RNA modifications and cancer (14 papers). Yong Wu collaborates with scholars based in China, United States and Ireland. Yong Wu's co-authors include Midie Xu, Weiwei Weng, Xiaohua Wu, Jun Zhu, Xingzhu Ju, Qiongyan Zhang, Zhenya Shen, Ping Wei, Meng Zhang and Qinhao Guo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yong Wu

109 papers receiving 2.4k citations

Peers

Yong Wu
Sergiu Șușman Romania
Lisette M. Acevedo United States
Yuh-Lih Chang Taiwan
Yueh Chien Taiwan
Reinhold J. Medina United Kingdom
Francesco Marampon Italy
Hui Meng China
Jin Hur South Korea
Xuetao Pei China
Effie C. Tsilibary United States
Sergiu Șușman Romania
Yong Wu
Citations per year, relative to Yong Wu Yong Wu (= 1×) peers Sergiu Șușman

Countries citing papers authored by Yong Wu

Since Specialization
Citations

This map shows the geographic impact of Yong Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Wu more than expected).

Fields of papers citing papers by Yong Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Wu. The network helps show where Yong Wu may publish in the future.

Co-authorship network of co-authors of Yong Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yong Wu. A scholar is included among the top collaborators of Yong Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong Wu. Yong Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fang, Chi, Yong Wu, Ying Wu, et al.. (2025). The effectiveness of anti-PD-L1 treatment and the underlying regulatory mechanism in ovarian clear cell carcinoma. International Immunopharmacology. 164. 115344–115344.
2.
Wu, Yangjun, Yu Zeng, Yong Wu, et al.. (2025). HIF‐1α‐induced long noncoding RNA LINC02776 promotes drug resistance of ovarian cancer by increasing polyADP‐ribosylation. Clinical and Translational Medicine. 15(3). e70244–e70244. 1 indexed citations
3.
Xia, Lingfang, et al.. (2025). m6A-modified circSTX6 as a key regulator of cervical cancer malignancy via SPI1 and IL6/JAK2/STAT3 pathways. Oncogene. 44(14). 968–982. 7 indexed citations
4.
Zhao, Xiaotong, Jing Dai, Xiaoyun Li, et al.. (2025). Biodegradable Piezoelectric Implant for Wirelessly Delivering Electrical Stimulation to the Heart under Ultrasound Stress. Advanced Functional Materials. 35(30). 3 indexed citations
5.
6.
Liu, Xia, Biwen Wu, Jiajun Li, et al.. (2025). AGR, LMR and SIRI are the optimal combinations for risk stratification in advanced patients with non-small cell lung cancer following immune checkpoint blockers. International Immunopharmacology. 149. 114215–114215. 3 indexed citations
7.
Xiao, Miao, Yong Wu, Yaning Wang, et al.. (2024). Injectable MXene conductive hydrogel improves myocardial infarction through scavenging ROS and repairing myocardium electrical integrity. Chemical Engineering Journal. 481. 148791–148791. 30 indexed citations
8.
Wu, Yong, Xiaofei Zhang, Zhongliang Ma, et al.. (2024). Tau Aggregation‐Dependent Lipid Peroxide Accumulation Driven by the hsa_circ_0001546/14‐3‐3/CAMK2D/Tau Complex Inhibits Epithelial Ovarian Cancer Peritoneal Metastasis. Advanced Science. 11(23). e2310134–e2310134. 8 indexed citations
9.
Wu, Jiangchun, Yong Wu, Siyu Chen, et al.. (2024). PARP1-stabilised FOXQ1 promotes ovarian cancer progression by activating the LAMB3/WNT/β-catenin signalling pathway. Oncogene. 43(12). 866–883. 8 indexed citations
10.
Zheng, Zhong, et al.. (2024). The value of surgery and the prognostic factors for patients with recurrent low-grade endometrial stromal sarcoma: a retrospective study of 38 patients. Journal of Gynecologic Oncology. 35(4). e98–e98. 1 indexed citations
11.
Guo, Qinhao, Linhao Qu, Jun Zhu, et al.. (2023). Predicting Lymph Node Metastasis From Primary Cervical Squamous Cell Carcinoma Based on Deep Learning in Histopathologic Images. Modern Pathology. 36(12). 100316–100316. 9 indexed citations
12.
Wu, Yangjun, Miao Xu, Zheng Feng, et al.. (2023). AUF1-induced circular RNA hsa_circ_0010467 promotes platinum resistance of ovarian cancer through miR-637/LIF/STAT3 axis. Cellular and Molecular Life Sciences. 80(9). 256–256. 17 indexed citations
13.
Shao, Yang, Hui Li, Yong Wu, et al.. (2023). The feedback loop of AURKA/DDX5/TMEM147-AS1/let-7 drives lipophagy to induce cisplatin resistance in epithelial ovarian cancer. Cancer Letters. 565. 216241–216241. 14 indexed citations
14.
Wang, Ziliang, Wei Chen, Ling Zuo, et al.. (2022). The Fibrillin‐1/VEGFR2/STAT2 signaling axis promotes chemoresistance via modulating glycolysis and angiogenesis in ovarian cancer organoids and cells. Cancer Communications. 42(3). 245–265. 101 indexed citations
15.
Hu, Zhengtao, Yangyang Zhang, Yin Yang, et al.. (2022). Inhibition of the ISR abrogates mGluR5-dependent long-term depression and spatial memory deficits in a rat model of Alzheimer’s disease. Translational Psychiatry. 12(1). 96–96. 35 indexed citations
16.
Yang, Yufei, Lingfang Xia, Yong Wu, et al.. (2021). Programmed death ligand‐1 regulates angiogenesis and metastasis by participating in the c‐JUN/VEGFR2 signaling axis in ovarian cancer. Cancer Communications. 41(6). 511–527. 42 indexed citations
17.
Wu, Yong, Qinhao Guo, Xingzhu Ju, et al.. (2021). HNRNPH1-stabilized LINC00662 promotes ovarian cancer progression by activating the GRP78/p38 pathway. Oncogene. 40(29). 4770–4782. 14 indexed citations
18.
19.
Xu, F. R., et al.. (2018). Overexpressing lncRNA SNHG16 inhibited HCC proliferation and chemoresistance by functionally sponging hsa-miR-93. SHILAP Revista de lepidopterología. 4 indexed citations
20.
Wang, Shaojia, Jiajia Li, Jie Xie, et al.. (2018). Programmed death ligand 1 promotes lymph node metastasis and glucose metabolism in cervical cancer by activating integrin β4/SNAI1/SIRT3 signaling pathway. Oncogene. 37(30). 4164–4180. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sergiu Șușman Breakdown of academic impact, for papers by Lisette M. Acevedo Breakdown of academic impact, for papers by Yuh-Lih Chang Breakdown of academic impact, for papers by Yueh Chien Breakdown of academic impact, for papers by Reinhold J. Medina Breakdown of academic impact, for papers by Francesco Marampon Breakdown of academic impact, for papers by Hui Meng Breakdown of academic impact, for papers by Jin Hur Breakdown of academic impact, for papers by Xuetao Pei Breakdown of academic impact, for papers by Effie C. Tsilibary
Rankless by CCL
2026